Literature DB >> 16307664

Severe cutaneous toxicity following treatment with gefitinib (ZD1839).

J C Pascual, I Belinchón, F Sivera, A Yuste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16307664     DOI： 10.1111/j.1365-2133.2005.06885.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

Review 1.  Metabolism considerations for kinase inhibitors in cancer treatment.

Authors:  Derek R Duckett; Michael D Cameron
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

2.  Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).

Authors:  Yohei Iimura; Naoki Furukawa; Masaaki Ishibashi; Yuka Ahiko; Taro Tanabe; Susumu Aikou; Dai Shida; Masanori Nojima; Seiichiro Kuroda; Narikazu Boku
Journal:  BMC Gastroenterol       Date:  2022-07-14       Impact factor: 2.847
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.